drugset / Trial / NCT06827457
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.
RandomizedParallel-groupDouble-blindOther
Summary
This study is designed to evaluate the safety, tolerability, PK and PD of GenSci120 in a randomized, double-blind, placebo-controlled trial involving healthy adult participants.
Timeline
- Start
- 2025-02-20
- Primary completion
- 2025-11-27
- Completion
- 2025-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenSci120 | Unknown | — | Subcutaneous |